OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
AMG 509 (Xaluritamig), an Anti-STEAP1 XmAb 2+1 T-cell Redirecting Immune Therapy with Avidity-Dependent Activity against Prostate Cancer
Olivier Nolan-Stevaux, Cong Li, Lingming Liang, et al.
Cancer Discovery (2023) Vol. 14, Iss. 1, pp. 90-103
Closed Access | Times Cited: 15
Olivier Nolan-Stevaux, Cong Li, Lingming Liang, et al.
Cancer Discovery (2023) Vol. 14, Iss. 1, pp. 90-103
Closed Access | Times Cited: 15
Showing 15 citing articles:
The present and future of bispecific antibodies for cancer therapy
Christian Klein, Ulrich Brinkmann, Janice M. Reichert, et al.
Nature Reviews Drug Discovery (2024) Vol. 23, Iss. 4, pp. 301-319
Closed Access | Times Cited: 131
Christian Klein, Ulrich Brinkmann, Janice M. Reichert, et al.
Nature Reviews Drug Discovery (2024) Vol. 23, Iss. 4, pp. 301-319
Closed Access | Times Cited: 131
Cancer therapy with antibodies
Suman Paul, Maximilian F. Konig, Drew M. Pardoll, et al.
Nature reviews. Cancer (2024) Vol. 24, Iss. 6, pp. 399-426
Closed Access | Times Cited: 55
Suman Paul, Maximilian F. Konig, Drew M. Pardoll, et al.
Nature reviews. Cancer (2024) Vol. 24, Iss. 6, pp. 399-426
Closed Access | Times Cited: 55
Bispecific and multispecific antibodies in oncology: opportunities and challenges
Maria-Elisabeth Goebeler, Gernot Stuhler, Ralf C. Bargou
Nature Reviews Clinical Oncology (2024) Vol. 21, Iss. 7, pp. 539-560
Closed Access | Times Cited: 35
Maria-Elisabeth Goebeler, Gernot Stuhler, Ralf C. Bargou
Nature Reviews Clinical Oncology (2024) Vol. 21, Iss. 7, pp. 539-560
Closed Access | Times Cited: 35
A pivotal decade for bispecific antibodies?
Marlena Surowka, Christian Klein
mAbs (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 20
Marlena Surowka, Christian Klein
mAbs (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 20
Xaluritamig, a STEAP1 × CD3 XmAb 2+1 Immune Therapy for Metastatic Castration-Resistant Prostate Cancer: Results from Dose Exploration in a First-in-Human Study
William K. Kelly, Daniel C. Danila, Chia‐Chi Lin, et al.
Cancer Discovery (2023) Vol. 14, Iss. 1, pp. 76-89
Open Access | Times Cited: 29
William K. Kelly, Daniel C. Danila, Chia‐Chi Lin, et al.
Cancer Discovery (2023) Vol. 14, Iss. 1, pp. 76-89
Open Access | Times Cited: 29
A Phase I Study of Acapatamab, a Half-life Extended, PSMA-Targeting Bispecific T-cell Engager for Metastatic Castration-Resistant Prostate Cancer
Tanya B. Dorff, Lisa G. Horvath, Karen A. Autio, et al.
Clinical Cancer Research (2024) Vol. 30, Iss. 8, pp. 1488-1500
Closed Access | Times Cited: 13
Tanya B. Dorff, Lisa G. Horvath, Karen A. Autio, et al.
Clinical Cancer Research (2024) Vol. 30, Iss. 8, pp. 1488-1500
Closed Access | Times Cited: 13
Progresses of T-cell-engaging bispecific antibodies in treatment of solid tumors
Junjun Liu, Jianwei Zhu
International Immunopharmacology (2024) Vol. 138, pp. 112609-112609
Closed Access | Times Cited: 5
Junjun Liu, Jianwei Zhu
International Immunopharmacology (2024) Vol. 138, pp. 112609-112609
Closed Access | Times Cited: 5
Facilitating high throughput bispecific antibody production and potential applications within biopharmaceutical discovery workflows
Caitlin Fawcett, Joseph Tickle, C.H. Coles
mAbs (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 4
Caitlin Fawcett, Joseph Tickle, C.H. Coles
mAbs (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 4
Bi-specific T-cell engagers (BiTEs) in prostate cancer and strategies to enhance development: hope for a BiTE-r future
Harriet Lampe, Laura Tam, Aaron R. Hansen
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 4
Harriet Lampe, Laura Tam, Aaron R. Hansen
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 4
The Pivotal Role of Preclinical Animal Models in Anti-Cancer Drug Discovery and Personalized Cancer Therapy Strategies
Haochuan Guo, Xinru Xu, Jiaxi Zhang, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 8, pp. 1048-1048
Open Access | Times Cited: 4
Haochuan Guo, Xinru Xu, Jiaxi Zhang, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 8, pp. 1048-1048
Open Access | Times Cited: 4
The Role of STEAP1 in Prostate Cancer: Implications for Diagnosis and Therapeutic Strategies
Lingling Zhang, Xinyi Ren, Ran An, et al.
Biomedicines (2025) Vol. 13, Iss. 4, pp. 794-794
Open Access
Lingling Zhang, Xinyi Ren, Ran An, et al.
Biomedicines (2025) Vol. 13, Iss. 4, pp. 794-794
Open Access
STEAP proteins: Roles in disease biology and potential for therapeutic intervention
Qiaomei Cai, Chao Jing, Xudong Wang, et al.
International Journal of Biological Macromolecules (2025), pp. 142797-142797
Closed Access
Qiaomei Cai, Chao Jing, Xudong Wang, et al.
International Journal of Biological Macromolecules (2025), pp. 142797-142797
Closed Access
Bispecific T-cell Engagers in Metastatic Castration-Resistant Prostate Cancer
Chadi Hage Chehade, Georges Gebrael, Neeraj Agarwal
Cancer Discovery (2024) Vol. 14, Iss. 1, pp. 20-22
Closed Access | Times Cited: 2
Chadi Hage Chehade, Georges Gebrael, Neeraj Agarwal
Cancer Discovery (2024) Vol. 14, Iss. 1, pp. 20-22
Closed Access | Times Cited: 2
Developmental Therapeutics in Metastatic Prostate Cancer: New Targets and New Strategies
Jingsong Zhang, Juskaran Chadha
Cancers (2024) Vol. 16, Iss. 17, pp. 3098-3098
Open Access | Times Cited: 2
Jingsong Zhang, Juskaran Chadha
Cancers (2024) Vol. 16, Iss. 17, pp. 3098-3098
Open Access | Times Cited: 2
Logic-gated and contextual control of immunotherapy for solid tumors: contrasting multi-specific T cell engagers and CAR-T cell therapies
Olivier Nolan-Stevaux, Richard Smith
Frontiers in Immunology (2024) Vol. 15
Open Access
Olivier Nolan-Stevaux, Richard Smith
Frontiers in Immunology (2024) Vol. 15
Open Access
